Arcturus Therapeutics Holdings, Inc. (ARCT)
10.47
+0.13
(+1.26%)
USD |
NASDAQ |
Oct 19, 15:33
Arcturus Therapeutics Holdings Cash from Operations (Annual) : -74.27M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -74.27M |
| December 31, 2024 | -59.75M |
| December 31, 2023 | -18.10M |
| December 31, 2022 | 31.99M |
| December 31, 2021 | -135.04M |
| December 31, 2020 | -42.86M |
| December 31, 2019 | -6.445M |
| December 31, 2018 | -20.76M |
| Date | Value |
|---|---|
| December 31, 2017 | -0.46M |
| December 31, 2016 | -2.861M |
| December 31, 2015 | -18.15M |
| December 31, 2014 | -28.33M |
| December 31, 2013 | -7.353M |
| December 31, 2012 | -1.585M |
| December 31, 2011 | -2.361M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 109.84M |
| Emergent BioSolutions, Inc. | 170.60M |
| Exelixis, Inc. | 884.27M |
| Ionis Pharmaceuticals, Inc. | -268.58M |
| United Therapeutics Corp. | 1.561B |